Thrive Acquisition Corporation
Status: Liquidated
U=S+W/2
W=S@11.5
IPO Proceeds, $M | $172.50M |
---|---|
IPO Date | Oct 21, 2021 |
CEO | Charles Jobson |
Left Lead | BTIG |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 15 + (3) |
IPO Sector |
Healthcare
Global health and wellness |
IPO Geography | Global |
Target Company | N/A |
Deal Announced | N/A |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
Closing Date | Jan 25, 2023 |
THAC
THACU
THACW
Price | |
---|---|
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Thrive Acquisition Corporation:
- Structure and cap table
- 7 directors & officers
- 7 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Charles Jobson | 61 | Chief Executive Officer and Director |
Charles Urbain | 67 | Chief Operating Officer, Chief Financial Officer, and Director |
Benjamin Kao | 45 | President and Director |
Peter Roy | 65 | Director |
James Macon | 45 | Director |
Daniel Germain | 48 | Director |
Peter Graham | 66 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
BTIG | BR | 14,250,000 | units |
I-Bankers Securities | 750,000 | ||
15,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 7 filings.